Once overlooked as the merely the human body’s plumbing, the lymphatic system is emerging as a new therapeutic frontier, ...

On this weeks episode of the Business of Biotech, Bret Bostwick, M.D., Venture Partner at Breyer Capital, a family office, talks about his path from medical geneticist to CNS drug development and ...

Life sciences distribution is shifting toward AI-powered, resilient networks that improve speed, efficiency, compliance, and ...

On this week's episode of the Business of Biotech, Simeon George, M.D., Cofounder and CEO at SR One Capital Management, returns to the show to talk about how SR One evaluates biotech investment ...

Years ago, a mentor recommended Clayton Christensen’s How Will You Measure Your Life? One story from the book has stayed with me. When Honda entered the U.S. motorcycle market, its deliberate strategy ...

In this segment from the Life Science Leader Live event "FDA Engagement Strategies and Best Practices Amid Agency Changes," the panel discusses regulatory intelligence and precedent research, why ...

In this segment from the Life Science Leader Live event "Crossing The Valley Of Death: New Funding Options For Preclinical And Early-Stage Drug Development," Anthony Aiudi and Jason Godfrey describe ...

In this segment from the Life Science Leader Live event "FDA Engagement Strategies and Best Practices Amid Agency Changes," Annetta Beauregard, SVP of Science & Regulatory Affairs, BIO, outlines her ...

In this segment from the Life Science Leader Live event "Crossing The Valley Of Death: New Funding Options For Preclinical And Early-Stage Drug Development," the panel examines how faster, ...

In this segment from the Life Science Leader Live event "FDA Engagement Strategies and Best Practices Amid Agency Changes," Jeremy Levin, Co-Founder and Executive Chairman, Ovid Therapeutics, and ...

In this segment from the Life Science Leader Live event "Crossing The Valley Of Death: New Funding Options For Preclinical And Early-Stage Drug Development," each panelist offers one piece of ...

In this segment from the Life Science Leader Live event "FDA Engagement Strategies and Best Practices Amid Agency Changes," Jeremy Levin, Co-Founder and Executive Chairman, Ovid Therapeutics, explains ...